Skip to main content
Year archive

ONCOSIL MEDICAL LTD — 2016 filings

All 46 regulatory filings released by ONCOSIL MEDICAL LTD (OSL) in 2016, sourced directly from the official regulator.

46 Filings
2016 Period
2016 filings (46)
Filing Released Lang
Pancreatic cancer clinical study update 3 pages 156.6KB
Regulatory Filings
2016-11-27 English
OncoSil Presents at Wilsons Rapid Insights Conference 24 pages 1.6MB
Investor Presentation
2016-11-09 English
Appendix 4C - Quarterly Cash Flow 8 pages 245.2KB
Interim / Quarterly Report
2016-10-26 English
Final Director's Interest Notice - Martin Rogers 4 pages 197.0KB
Director's Dealing
2016-10-18 English
CEO Presentation - AGM 18th October 2016 15 pages 1.2MB
Investor Presentation
2016-10-17 English
2016 Results od Annual General Meeting 2 pages 142.2KB
Declaration of Voting Results & Voting Rights Announcements
2016-10-17 English
Receipt of $2.3m R & D Tax Incentive Refund 2 pages 135.5KB
Capital/Financing Update
2016-09-25 English
2016 Amended - Appendix 4G 17 pages 706.6KB
Governance Information
2016-09-12 English
2016 Annual Report 57 pages 1.9MB
Annual Report
2016-09-11 English
2016 Corporate Governance - Appendix 4G 17 pages 697.0KB
Regulatory Filings
2016-09-11 English
2016 AGM Notice of Meeting - Proxy Form 14 pages 340.3KB
AGM Information
2016-09-11 English
Appendix 4E - Preliminary final report 30 June 2016 49 pages 694.7KB
Annual Report
2016-08-29 English
Investor Presentation - Aug 2016 26 pages 1.7MB
Investor Presentation
2016-08-21 English
Hot Calibration Run of the OncoSil Device 2 pages 133.1KB
Regulatory Filings
2016-08-17 English
Appendix 3B 12 pages 158.6KB
Capital/Financing Update
2016-08-11 English
FDA IDE Approval 3 pages 650.1KB
Capital/Financing Update
2016-08-01 English
Appendix 4C - Quarterly Cash Flow 9 pages 860.6KB
Interim / Quarterly Report
2016-07-26 English
48th European Pancreatic Club meeting 2 pages 134.7KB
Regulatory Filings
2016-07-05 English
Appendix 3B & Cleansing 13 pages 244.8KB
Share Issue/Capital Change
2016-06-29 English
Regulatory Update June 2016 2 pages 144.2KB
Regulatory Filings
2016-06-29 English
Appoints Global Sales and Marketing Director 2 pages 131.9KB
Board/Management Information
2016-05-17 English
Cleansing Notice & Appendix 3B 13 pages 869.5KB
Capital/Financing Update
2016-05-12 English
Appendix 3B 12 pages 534.4KB
Capital/Financing Update
2016-05-09 English
Results of Extraordinary General Meeting 1 page 358
Declaration of Voting Results & Voting Rights Announcements
2016-05-08 English
OncoSil Medical Presents at Asia BiotechInvest 25 pages 1.9MB
Investor Presentation
2016-05-03 English
Appendix 4C - Quarterly Cashflow 9 pages 221.6KB
Interim / Quarterly Report
2016-04-27 English
OncoSil Medical Change of Address 2 pages 103.6KB
Regulatory Filings
2016-04-18 English
Cleansing Notice and Appendix 3B 14 pages 255.6KB
Capital/Financing Update
2016-04-14 English
OncoSil EGM Notice of Meeting 20 pages 175.5KB
Proxy Solicitation & Information Statement
2016-04-07 English
OncoSil Medical releases latest Investor Presentation 25 pages 1.1MB
Investor Presentation
2016-03-22 English
Withdrawal of Extraordinary General Meeting 2 pages 400.2KB
Regulatory Filings
2016-03-21 English
OncoSil Market Update March 1 2 pages 101.1KB
Regulatory Filings
2016-02-29 English
Notice of Extraordinary General Meeting/Proxy Form 21 pages 182.1KB
Proxy Solicitation & Information Statement
2016-02-24 English
Appendix 4D & Half Year Accounts 19 pages 403.4KB
Interim / Quarterly Report
2016-02-14 English
Ceasing to be a substantial holder 2 pages 1.1MB
Regulatory Filings
2016-02-10 English
Notice of change of substantial holder 2 pages 133.2KB
Major Shareholding Notification
2016-02-10 English
Cleansing Notice & Appendix 3B 14 pages 262.7KB
Capital/Financing Update
2016-02-09 English
Becoming a substantial holder 2 pages 124.0KB
Regulatory Filings
2016-02-08 English
$10 Million Institutional Placement 2 pages 422.1KB
Capital/Financing Update
2016-02-02 English
Notification of change of Share Registry 1 page 89.
Regulatory Filings
2016-01-28 English
Appendix 4C - Quarterly Cashflow 8 pages 606.8KB
Interim / Quarterly Report
2016-01-27 English
Initial Directors interest 2 pages 199.2KB
Director's Dealing
2016-01-24 English
Dr Chris Roberts - appointed Non-Executive Director 2 pages 135.8KB
Board/Management Information
2016-01-20 English
OncoSil Medical Cleansing Notice & Appendix 3B 15 pages 895.7KB
Regulatory Filings
2016-01-20 English
Appendix 3B 13 pages 535.8KB
Share Issue/Capital Change
2016-01-12 English
Share Option Vesting Conditions Met 2 pages 334.8KB
Capital/Financing Update
2016-01-06 English